Application no. and date | 17844404.8 (espacenet) (Federated) (European Patent Register), 20170824 | Patent/reg. no. and date | DK/EP 3504229, 20211013 | Publication date | 20190703 | Priority no. and date | US 201662378978 P, 20160824, US 201762443981 P, 20170109, US 201762545778 P, 20170815 | EP pub. no. and date |
EP 3504229 20190703 | Effective date | | Applicant/owner | Sangamo Therapeutics, Inc., 7000 Marina Blvd
Brisbane, CA 94005, US | Applicant ref. no. | 1615804 | Inventor | MILLER, Jeffrey C., c/o Sangamo Therapeutics Inc. 7000 Marina Blvd
Brisbane California 94005, US, REBAR, Edward J., c/o Sangamo Therapeutics Inc. 7000 Marina Blvd
Brisbane California 94005, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 35/28 (2015.01) , A61K 38/00 (2006.01) , A61P 7/00 (2006.01) , A61P 7/06 (2006.01) , C12N 15/90 (2006.01) , C12N 9/22 (2006.01) | Title | REGULERING AF GENEKSPRESSION VED ANVENDELSE AF MANIPULEREDE NUKLEASER | Int. application no. | US2017048397 | Int. publication no. | WO2018039440 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|